Cargando…

Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study

BACKGROUND: Germline mutations in cancer susceptibility genes were identified in pancreatic cancer (PanC) patients with a sporadic disease and in those unselected for family cancer history. METHODS: With the aim to determine the prevalence of germline predisposition genes mutations in PanC, and to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tavano, Francesca, Gioffreda, Domenica, Fontana, Andrea, Palmieri, Orazio, Gentile, Annamaria, Latiano, Tiziana, Latiano, Anna, Latiano, Tiziana Pia, Scaramuzzi, Matteo, Maiello, Evaristo, Bazzocchi, Francesca, Perri, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885574/ https://www.ncbi.nlm.nih.gov/pubmed/36717774 http://dx.doi.org/10.1186/s10020-023-00600-1

Ejemplares similares

Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
por: Tavano, Francesca, et al.
Publicado: (2018)

Downexpression of miR-200c-3p Contributes to Achalasia Disease by Targeting the PRKG1 Gene
por: Micale, Lucia, et al.
Publicado: (2022)

Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis
por: Palmieri, Orazio, et al.
Publicado: (2023)

False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy
por: Latiano, Anna, et al.
Publicado: (2021)

Adherence to Gluten-Free Diet Restores Alpha Diversity in Celiac People but the Microbiome Composition Is Different to Healthy People
por: Palmieri, Orazio, et al.
Publicado: (2022)

Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
por: Mazza, Tommaso, et al.
Publicado: (2020)

Microbiome Analysis of Mucosal Ileoanal Pouch in Ulcerative Colitis Patients Revealed Impairment of the Pouches Immunometabolites
por: Palmieri, Orazio, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Microbiota Manipulation by Probiotics Administration as Emerging Tool in Cancer Prevention and Therapy
por: Panebianco, Concetta, et al.
Publicado: (2020)

Investigation of Multiple Susceptibility Loci for Inflammatory Bowel Disease in an Italian Cohort of Patients
por: Latiano, Anna, et al.
Publicado: (2011)

Addendum: Palmieri, O. et al. Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling. Int. J. Mol. Sci. 2017, 18, 1580
por: Palmieri, Orazio, et al.
Publicado: (2017)

Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling
por: Palmieri, Orazio, et al.
Publicado: (2017)

Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer
por: Panza, Anna, et al.
Publicado: (2020)

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches
por: Parente, Paola, et al.
Publicado: (2018)

High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer
por: Trivieri, Nadia, et al.
Publicado: (2020)

A PCR-based method for the diagnosis of Enterobius vermicularis in stool samples, specifically designed for clinical application
por: Ummarino, Aldo, et al.
Publicado: (2022)

Circulating levels of cytokines, chemokines and growth factors in patients with achalasia
por: Panza, Anna, et al.
Publicado: (2021)

Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
por: Panebianco, Concetta, et al.
Publicado: (2021)

Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia
por: Palmieri, Orazio, et al.
Publicado: (2016)

Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial
por: Martini, Giulia, et al.
Publicado: (2023)

Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941
por: Ciardiello, Davide, et al.
Publicado: (2022)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

Crohn’s Disease Localization Displays Different Predisposing Genetic Variants
por: Palmieri, Orazio, et al.
Publicado: (2017)

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)
por: Giommoni, Elisa, et al.
Publicado: (2021)

Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease
por: Palmieri, Orazio, et al.
Publicado: (2015)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

New biologics in the management of Crohn’s disease: focus on certolizumab pegol
por: Colombo, Elisabetta, et al.
Publicado: (2009)

Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
por: Latiano, Anna, et al.
Publicado: (2013)

RS-SNP: a random-set method for genome-wide association studies
por: D'Addabbo, Annarita, et al.
Publicado: (2011)

Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis
por: Tavano, Francesca, et al.
Publicado: (2020)

Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy
por: Ciardiello, Davide, et al.
Publicado: (2021)

Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
por: Panebianco, Concetta, et al.
Publicado: (2021)

Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS(G12D) mutated pancreatic cancer in vivo model
por: Panebianco, Concetta, et al.
Publicado: (2023)

BRAF(V600E) mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies
por: Trivieri, Nadia, et al.
Publicado: (2020)

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment
por: Martinelli, Erika, et al.
Publicado: (2017)

Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
por: Massimino, Luca, et al.
Publicado: (2023)

Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report
por: Guida, Claudio Carmine, et al.
Publicado: (2023)

Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
por: Di Gangi, Iole Maria, et al.
Publicado: (2016)

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy
por: Del Re, Marzia, et al.
Publicado: (2014)

Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients
por: Fontana, Andrea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_okd7elc2tlkksesiqca9q0t3eq